Your browser doesn't support javascript.
loading
Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study).
Hermans, Michel; Van Gaal, Luc; Rézette, Ingrid; Daci, Evis; MacDonald, Karen; Denhaerynck, Kris; Vancayzeele, Stefaan; De Meester, Lut; Clemens, Andreas; Yee, Brian; Abraham, Ivo.
Afiliação
  • Hermans M; Cliniques Universitaires Saint-Luc, Avenue Hippocrate 55, B-1200 Bruxelles, Belgium. Electronic address: michel.hermans@uclouvain.be.
  • Van Gaal L; Universitair Ziekenhuis Antwerpen, Wilrijkstraat 10, B-2650 Edegem, Belgium. Electronic address: luc.van.gaal@uza.be.
  • Rézette I; Novartis Pharma, Medialaan 40, bus 1, B-1800 Vilvoorde, Belgium. Electronic address: ingrid.rezette@gmail.com.
  • Daci E; Novartis Pharma, Medialaan 40, bus 1, B-1800 Vilvoorde, Belgium. Electronic address: evis.daci@novartis.com.
  • MacDonald K; Matrix45, 6159 W Sunset Rd, Tucson, AZ, USA. Electronic address: kmacdonald@matrix45.com.
  • Denhaerynck K; Matrix45, 6159 W Sunset Rd, Tucson, AZ, USA. Electronic address: kdenhaerynck@matrix45.com.
  • Vancayzeele S; Novartis Pharma, Medialaan 40, bus 1, B-1800 Vilvoorde, Belgium. Electronic address: stefaan.vancayzeele@novartis.com.
  • De Meester L; Novartis Pharma, Medialaan 40, bus 1, B-1800 Vilvoorde, Belgium. Electronic address: lut.demeester@novartis.com.
  • Clemens A; Novartis Pharma, Novartis Campus, CH-4056 Basel, Switzerland. Electronic address: andreas.clemens@novartis.com.
  • Yee B; Matrix45, 6159 W Sunset Rd, Tucson, AZ, USA. Electronic address: byee@matrix45.com.
  • Abraham I; Matrix45, 6159 W Sunset Rd, Tucson, AZ, USA; Center for Health Outcomes and Pharmacoeconomic Research, University of Arizona, 1295 N Martin Ave, Tucson, AZ 85743, USA. Electronic address: iabraham@matrix45.com.
Prim Care Diabetes ; 10(6): 425-433, 2016 12.
Article em En | MEDLINE | ID: mdl-27388795

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Participação do Paciente / Pirrolidinas / Glicemia / Adamantano / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Hipoglicemiantes / Metformina / Nitrilas Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Participação do Paciente / Pirrolidinas / Glicemia / Adamantano / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Hipoglicemiantes / Metformina / Nitrilas Idioma: En Ano de publicação: 2016 Tipo de documento: Article